These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6154747)

  • 21. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 22. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 23. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW; Skurzak HM; Klein E; Wigzell H
    J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract]   [Full Text] [Related]  

  • 25. Alloimmunization and adoptive immunotherapy of leukemia.
    Truitt RL; Shih CY; Rimm AA; Tempelis LD; Bortin MM
    Transplant Proc; 1981 Dec; 13(4):1910-4. PubMed ID: 6949385
    [No Abstract]   [Full Text] [Related]  

  • 26. Recognition of GIX-linked minor histocompatibility antigens by H-2-restricted cytotoxic T lymphocytes from C57BL/6-GIX+ mice: an approach to mapping the genes controlling GIX.
    Green WR
    J Immunol; 1982 Feb; 128(2):920-5. PubMed ID: 6172516
    [No Abstract]   [Full Text] [Related]  

  • 27. Serological analysis of H-2 antigens expression on the cell surface of selected mouse tumors.
    Opolski A; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(1):7-17. PubMed ID: 3778116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

  • 29. Embryonic antigens in tumor immunity.
    Della Porta G
    Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in H-2 antigen expression on a murine spontaneous leukaemia (K36) detected by cell-mediated cytotoxicity assay.
    Testorelli C; Marelli O; Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):19-29. PubMed ID: 6154749
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular features of the H-2 class I and Qa antigens expressed on Gross virus induced AKR leukaemias.
    Festenstein H
    J Immunogenet; 1989; 16(4-5):329-33. PubMed ID: 2700994
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains.
    Hilgers J; Galesloot J
    Int J Cancer; 1973 May; 11(3):780-93. PubMed ID: 4364724
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular immune response to a drug-treated L5178Y lymphoma subline.
    Nicolin A; Bini A; Coronetti E; Goldin A
    Nature; 1974 Oct; 251(5476):654-5. PubMed ID: 4138894
    [No Abstract]   [Full Text] [Related]  

  • 34. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
    Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
    [No Abstract]   [Full Text] [Related]  

  • 35. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alienation of tumor immunity: alien-driven diversity and alien-selected escape.
    Sondel PM; Bach FH
    Transplant Proc; 1980 Mar; 12(1):211-5. PubMed ID: 6154356
    [No Abstract]   [Full Text] [Related]  

  • 37. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules.
    Fox RI; Weissman IL
    J Immunol; 1979 May; 122(5):1697-704. PubMed ID: 87439
    [No Abstract]   [Full Text] [Related]  

  • 39. Surface expression of alien hybrid IE/C antigens on the reticulum cell sarcoma of SJL/J mice.
    Bonavida B; Wilbur SM; Marelli O
    Transplant Proc; 1981 Dec; 13(4):1833-6. PubMed ID: 7036479
    [No Abstract]   [Full Text] [Related]  

  • 40. [Origin of effector and rosette-forming cells in transplantation immunity in mice].
    Brondz BD; Kotomina IF
    Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.